Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...
Japanese scientists conducted a clinical trial using stem cells to treat severe corneal damage. The trial involved four ...
It happens when a parasite that can be found in water invades the eye, damaging the cornea, causing severe pain and ...
A trip to the beach has turned Brooklyn McCasland’s life upside down after she contracted a vision-threatening eye infection ...
Researchers led by Osaka University in Japan have conducted the first human trial using induced pluripotent stem-cell-derived ...